Diagnostic Window Prior to a Haematological Cancer Diagnosis and the Association With Patient Pathways: A Nationwide

Line Flytkjær Virgilsen1, Peter Vedsted1,2, Henry Jensen3

  • 1Research Unit for General Practice, Aarhus, Denmark.

PubMed

Insights

Healthcare use increased in the two years before a haematological cancer diagnosis, particularly for women, suggesting a potential diagnostic window for earlier detection of these blood cancers.

Area of Science:

  • Oncology
  • Epidemiology
  • Health Services Research

Background:

  • Hematological cancers, including leukemia, multiple myeloma, and lymphoma, pose significant health challenges.
  • Early detection of hematological malignancies is crucial for improving patient outcomes.
  • Understanding pre-diagnostic healthcare utilization patterns can inform early diagnostic strategies.

Purpose of the Study:

  • To investigate healthcare utilization in general practice and hospitals in the two years preceding a hematological cancer diagnosis.
  • To analyze the association between pre-diagnostic healthcare use and patient pathways (unplanned vs. elective routes).

Main Methods:

  • A nationwide register-based cohort study included 12,994 patients diagnosed with leukemia, multiple myeloma, or lymphoma between 2014-2018.
  • Matched references were used for comparison.
  • Patient pathways were categorized into unplanned (acute admission) and elective routes.

Main Results:

  • Female patients showed increased general practice contacts and healthcare utilization (point-of-care tests, hospital visits, radiological investigations) up to 24 months before diagnosis.
  • Male patients exhibited similar patterns, albeit with a later onset.
  • No significant differences in healthcare use were observed between unplanned and elective diagnostic pathways.

Conclusions:

  • A notable increase in healthcare utilization in primary and secondary care was observed up to two years before a hematological cancer diagnosis.
  • These findings suggest a potential 'diagnostic window' that could be leveraged for earlier detection of hematological cancers.
Abstract